Three-tiered fluorescence-based system for monitoring activation-related changes in human platelets

A method for simultaneous fluorescence spectroscopic measurement of surface membrane fluidity, platelet aggregation, and intracellular calcium concentration was developed. The capacity of the system to assess platelet activation associated with coronary artery angioplasty and anti-platelet treatment was confirmed. This approach offers a new analytical technique for circulating platelet activation.

[1]  J Jesty,et al.  Acetylated prothrombin as a substrate in the measurement of the procoagulant activity of platelets: elimination of the feedback activation of platelets by thrombin. , 1999, Analytical biochemistry.

[2]  D. Praticò,et al.  Hydrogen peroxide triggers activation of human platelets selectively exposed to nonaggregating concentrations of arachidonic acid and collagen. , 1992, The Journal of laboratory and clinical medicine.

[3]  J. Desager.  Clinical Pharmacokinetics of Ticlopidine , 1994, Clinical pharmacokinetics.

[4]  H. Miller,et al.  Serum amyloid type a may be a predictor of restenosis , 1998, Clinical cardiology.

[5]  H. Weiss,et al.  Enhanced Increases in Cytosolic Ca2+ in ADP-Stimulated Platelets from Patients with Delta-Storage Pool Deficiency – A Possible Indicator of Interactions between Granule-Bound ADP and the Membrane ADP Receptor , 1997, Thrombosis and Haemostasis.

[6]  T. Inoue,et al.  Early detection of platelet activation after coronary angioplasty , 1996, Coronary artery disease.

[7]  J. Kermode,et al.  Ristocetin-mediated interaction of human von Willebrand factor with platelet glycoprotein lb evokes a transient calcium signal: observations with Fura-PE3. , 1998, Journal of Laboratory and Clinical Medicine.

[8]  J. Heemskerk,et al.  Membrane fluidity of non-activated and activated human blood platelets. , 1990, Biochimica et biophysica acta.

[9]  P. Gazzaniga,et al.  Hydrogen peroxide is involved in collagen-induced platelet activation. , 1998, Blood.

[10]  C. O'connor,et al.  Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure. , 1999, The American journal of cardiology.

[11]  G. FitzGerald,et al.  Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. , 1997, The Journal of clinical investigation.

[12]  P. Seth,et al.  Platelet aggregability and occurrence of restenosis following coronary angioplasty. , 1997, International journal of cardiology.

[13]  K Fujikawa,et al.  Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D Barnett,et al.  Flow cytometric quantitation of immunofluorescence intensity: problems and perspectives. European Working Group on Clinical Cell Analysis. , 1998, Cytometry.

[15]  T. Böhm,et al.  Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. , 1999, Circulation.

[16]  M. Nakanishi,et al.  Multidimensional stopped-flow photometry monitoring initial processes of platelet activation. , 1987, Journal of biochemistry.

[17]  S. Raha,et al.  Correlation of membrane anisotropy with function in subpopulations of human blood platelets * , 1989, British journal of haematology.

[18]  H. Weiss,et al.  Evidence for a role of glycoprotein IIb-IIIa, distinct from its ability to support aggregation, in platelet activation by ionophores in the presence of extracellular divalent cations. , 1994, Blood.

[19]  V. Duranthon,et al.  Plasma Lipids and Platelet Membrane Fluidity in Essential Hypertension , 1993, Thrombosis and Haemostasis.

[20]  C. Carlini,et al.  Stimulation of calcium influx and platelet activation by canatoxin: methoxyverapamil inhibition and downregulation by cGMP. , 1997, Archives of biochemistry and biophysics.